Literature DB >> 19349785

The role of genetics in susceptibility to diabetic retinopathy.

Gerald Liew1, Ronald Klein, Tien Y Wong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349785      PMCID: PMC2746819          DOI: 10.1097/IIO.0b013e31819fd5d7

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  94 in total

1.  Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.

Authors:  D K Nagi; L J McCormack; V Mohamed-Ali; J S Yudkin; W C Knowler; P J Grant
Journal:  Diabetes Care       Date:  1997-08       Impact factor: 19.112

2.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

Authors:  G Imperatore; R L Hanson; D J Pettitt; S Kobes; P H Bennett; W C Knowler
Journal:  Diabetes       Date:  1998-05       Impact factor: 9.461

3.  Genetics of diabetic complications.

Authors:  J Alcolado
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Retinopathy in older persons without diabetes and its relationship to hypertension.

Authors:  T Yu; P Mitchell; G Berry; W Li; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-01

7.  Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.

Authors:  M I Harris; R Klein; C C Cowie; M Rowland; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

Authors:  B C Ko; K S Lam; N M Wat; S S Chung
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

View more
  38 in total

Review 1.  Challenges in elucidating the genetics of diabetic retinopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Jerome I Rotter
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

Review 2.  Genetics of diabetic retinopathy.

Authors:  Heeyoon Cho; Lucia Sobrin
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

3.  Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.

Authors:  Danfeng Peng; Jie Wang; Rong Zhang; Feng Jiang; Shanshan Tang; Miao Chen; Jing Yan; Xue Sun; Shiyun Wang; Tao Wang; Dandan Yan; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  Diabetologia       Date:  2015-03-28       Impact factor: 10.122

Review 4.  Unraveling the role of genetics in the pathogenesis of diabetic retinopathy.

Authors:  Ashok Sharma; Maria L Valle; Connor Beveridge; Yutao Liu; Shruti Sharma
Journal:  Eye (Lond)       Date:  2019-01-24       Impact factor: 3.775

5.  Meta-analysis of the association between aldose reductase gene (CA)n microsatellite variants and risk of diabetic retinopathy.

Authors:  Wensheng Mi; Yan Xia; Yanhui Bian
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

6.  Association of vascular endothelial growth factor -634G/C and receptor for advanced glycation end products G82S gene polymorphisms with diabetic retinopathy.

Authors:  Asmaa Kamal; Khaled Abu Eleinen; Ibrahem Siam
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 7.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 8.  Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy.

Authors:  Cindy Ung; Angie V Sanchez; Lishuang Shen; Samaneh Davoudi; Tina Ahmadi; Daniel Navarro-Gomez; Ching J Chen; Heather Hancock; Alan Penman; Suzanne Hoadley; Mark Consugar; Carlos Restrepo; Vinay A Shah; Joseph F Arboleda-Velasquez; Lucia Sobrin; Xiaowu Gai; Leo A Kim
Journal:  Vision Res       Date:  2017-05-09       Impact factor: 1.886

9.  Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus.

Authors:  Ping-Ping Dong
Journal:  J Clin Lab Anal       Date:  2018-10-23       Impact factor: 2.352

10.  Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population.

Authors:  Shu Liang; Min Pan; Nan Hu; Yu-Yu Wu; Hui Chen; Jian-Hua Zhu; Huai-Jin Guan; Ai-Min Sang
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.